Elevated hsCRP is associated with respiratory symptoms in COPD

E. Lagrange (Umeå, Sweden), U. Nilsson (Umeå, Sweden), L. Hedman (Umeå, Sweden), C. Stridsman (Umeå, Sweden), H. Backman (Umeå, Sweden), A. Lindberg (Umeå, Sweden), A. Blomberg (Umeå, Sweden)

Source: International Congress 2019 – More and more COPD
Session: More and more COPD
Session type: Thematic Poster
Number: 4430
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Lagrange (Umeå, Sweden), U. Nilsson (Umeå, Sweden), L. Hedman (Umeå, Sweden), C. Stridsman (Umeå, Sweden), H. Backman (Umeå, Sweden), A. Lindberg (Umeå, Sweden), A. Blomberg (Umeå, Sweden). Elevated hsCRP is associated with respiratory symptoms in COPD. 4430

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018



Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1515-1516
Year: 2015


Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1514-1515
Year: 2015


Increased plasma fibrinogen could predict frequent exacerbations in asthma
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters
Source: Eur Respir J 2001; 18: Suppl. 33, 75s
Year: 2001

Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018



Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008


Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Low plasma CC16 levels in smokers are associated with a higher risk for chronic bronchitis
Source: Eur Respir J 2015; 46: 1501-1503
Year: 2015


Plasma surfactant protein A levels are increased in smokers but do not correlate with respiratory symptoms and airway obstruction
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010

Markers of systemic inflammation are associated with increased symptoms and respiratory exacerbations among smokers with preserved spirometry in SPIROMICS
Source: International Congress 2018 – Biomarkers in COPD and asthma
Year: 2018



Elevated c-reactive protein (CRP) levels in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 332s
Year: 2004

Factors affecting C-reactive protein levels in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015


Elevation of NTproBNP in hypercapnic chronic respiratory failure and relation to the severity of the disease
Source: Eur Respir J 2005; 26: Suppl. 49, 350s
Year: 2005

Coexisting chronic diseases in COPD – cause of elevated level of C-reactive protein?
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007


The importance of C-reactive protein in patients with acute exacerbation of severe COPD
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019

KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome
Source: Eur Respir J 2004; 23: 142-145
Year: 2004